Strolll, founded in 2019, is carving a niche in the Health Care and Medical Devices sectors with its innovative use of Augmented Reality technology. Operating out of the United Kingdom, the company specializes in developing Digital Therapeutics software that enhances movement therapy for individuals with neurological disorders. This capability is encapsulated in their slogan: "Augmented Reality for Neurorehabilitation."
In March 2025, Strolll secured a £10.35M Series A investment from IW Capital, underscoring the significant investor confidence in their potential. The company's focus on leveraging AR technology to address critical needs within neurorehabilitation positions it well in the convergence of VR/AR and health care industries.
Strolll represents a compelling investment opportunity, given the rising demand for technological innovations in therapeutic solutions and the increasing prevalence of neurological conditions worldwide.